# Diabetes Treatment With Glucobay in Combination With Sulfonylurea

> **NCT01613105** · — · COMPLETED · sponsor: **Bayer** · enrollment: 4564 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Acarbose (Precose/Glucobay, BAYG5421)

## Key facts

- **NCT ID:** NCT01613105
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 4564 (ACTUAL)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01613105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01613105, "Diabetes Treatment With Glucobay in Combination With Sulfonylurea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01613105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*